Impact of antibiotic-resistant Gram-negative bacilli infections on outcome in hospitalized patients.
about
Rhamnolipids are virulence factors that promote early infiltration of primary human airway epithelia by Pseudomonas aeruginosaBench-to-bedside review: antimicrobial utilization strategies aimed at preventing the emergence of bacterial resistance in the intensive care unit.Association between infections caused by multidrug-resistant gram-negative bacteria and mortality in critically ill patientsImprovements in pulmonary and general critical care reduces mortality following ventilator-associated pneumoniaAggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infection: a quasi-experimental, before and after observational cohort study.Infections caused by multidrug resistant organisms are not associated with overall, all-cause mortality in the surgical intensive care unit: the 20,000 foot view.Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of AmericaIncidence and predictors of surgical site infections following caesarean sections at Bugando Medical Centre, Mwanza, Tanzania.Multidrug resistant Pseudomonas aeruginosa infection in children undergoing chemotherapy and hematopoietic stem cell transplantation.Antibiotic resistance in sepsis patients: evaluation and recommendation of antibiotic use.Impact of ureido/carboxypenicillin resistance on the prognosis of ventilator-associated pneumonia due to Pseudomonas aeruginosa.Risk and Prognostic Factors for Multidrug-Resistant Acinetobacter Baumannii Complex Bacteremia: A Retrospective Study in a Tertiary Hospital of West ChinaCentral venous catheter-related bacteremia due to gram-negative bacilli: significance of catheter removal in preventing relapse.Resistance to antimicrobial agents: an update.Influence of multidrug resistance and appropriate empirical therapy on the 30-day mortality rate of Pseudomonas aeruginosa bacteremia.Antimicrobial resistance and patient outcomes: the hazards of adjustmentClinical Outcomes and Healthcare Utilization Related to Multidrug-Resistant Gram-Negative Infections in Community Hospitals.Antimicrobial use and microbiological testing in district general hospital ICUs of the Veneto region of north-east Italy.Risk factors for the first episode of Klebsiella pneumoniae resistant to carbapenems infection in critically ill patients: a prospective study.Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004.Effect of nosocomial infections due to antibiotic-resistant organisms on length of stay and mortality in the pediatric intensive care unit.Microbiology of surgical site infections and associated antimicrobial use among Vietnamese orthopedic and neurosurgical patients.Risk factors for and influence of bloodstream infections on mortality: a 1-year prospective study in a Greek intensive-care unit.Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality.Comment: tigecycline for the treatment of Acinetobacter infections: a case series.Predictors of in-hospital mortality for bloodstream infections caused by Enterobacter species or Citrobacter freundii.
P2860
Q24548276-9EBE4BEC-B194-4A43-9CFA-603B3EDAA34BQ24813204-C0F7B8BC-998A-4D05-83EF-A74A4F24CD1FQ26751621-AC7DF530-E1AF-4958-91DF-FEADC26C1493Q30415079-0E65771E-1B3F-4292-960E-63CF0D7FAECEQ30416983-50F300B7-2F04-4396-8200-0F20F912F0D5Q30419577-D256401F-9BFC-4630-8610-C29AB68DCDFFQ33688646-9E8061D9-45CE-4118-843A-9C4A39A25F31Q34040521-732E34A1-E8F8-4A11-90F4-1B217133F12DQ34095684-1D05EB60-4016-46F6-A90B-861A939BFC24Q34908030-F1A8112C-1F0B-4C18-8DF3-CB1D9C8A7851Q35559596-F374DF9E-FF9E-480A-8D5A-32A357BBC066Q35666047-69CFE7C6-4142-402D-9608-9D49CA8451D9Q35882513-B8997EDF-5EED-45ED-8CD6-75C8D4DA0120Q35976850-38CAB11A-AFFD-4914-9E8C-A2044C773402Q36172460-8A391E3C-C0D1-4173-995B-66F396A2DD5CQ36596794-2825A479-4924-4A10-AA4C-CACD7C1531B8Q39304889-7E11FACC-0BBE-4840-98C4-2F56BC051D66Q40701338-F242B56C-E28D-4AC9-A67F-8A89AB025F9CQ41846236-B28ACC37-D2E4-4639-9EA9-55E986E29B46Q42637997-C05E0555-3B5F-4EAF-84F0-6E7E41BCC3B3Q43603202-F4AB7CD3-5DC6-4A11-AEBE-2E736386A8C4Q44415321-1D730E63-9299-4422-A293-D5E202251711Q44583740-C7EC4C8A-BC66-45D8-822A-239460AADCC8Q45365673-1C03202B-D39D-44D1-ABAF-2100F20C8AD1Q46338529-78C94BB9-8002-4057-9FAE-B6D9834B45E2Q51924519-F9BF1CC9-7028-4E1C-9A0F-348455C2FD66
P2860
Impact of antibiotic-resistant Gram-negative bacilli infections on outcome in hospitalized patients.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Impact of antibiotic-resistant ...... come in hospitalized patients.
@ast
Impact of antibiotic-resistant ...... come in hospitalized patients.
@en
type
label
Impact of antibiotic-resistant ...... come in hospitalized patients.
@ast
Impact of antibiotic-resistant ...... come in hospitalized patients.
@en
prefLabel
Impact of antibiotic-resistant ...... come in hospitalized patients.
@ast
Impact of antibiotic-resistant ...... come in hospitalized patients.
@en
P2093
P50
P921
P1476
Impact of antibiotic-resistant ...... come in hospitalized patients.
@en
P2093
Daniel P Raymond
Shawn J Pelletier
Traves D Crabtree
P304
P356
10.1097/01.CCM.0000060015.77443.31
P407
P577
2003-04-01T00:00:00Z